Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multimerization of polyomavirus middle-T antigen

M Senften1, S Dilworth, K Ballmer-Hofer

  • 1Friedrich Miescher Institute, Basel, Switzerland.

Journal of Virology
|September 1, 1997
PubMed
Summary

Polyomavirus middle-T antigen forms dimers for cell signaling, requiring membrane association but not 14-3-3 proteins for oncogenic activity. Membrane targeting is key for middle-T antigen dimerization and oncogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain.

The Journal of physiology·2018
Same author

Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia.

Neurobiology of disease·2014
Same author

The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space.

Swiss medical weekly·2011
Same author

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2.

Cellular and molecular life sciences : CMLS·2006
Same author

Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach.

British journal of cancer·2006
Same author

The role of VEGF receptors in angiogenesis; complex partnerships.

Cellular and molecular life sciences : CMLS·2006

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Virology

Background:

  • The polyomavirus middle-T antigen is an oncogenic protein that interacts with cellular proteins involved in mitogenic signaling.
  • It mimics cellular tyrosine kinase growth factor receptors, initiating signaling cascades upon ligand binding and receptor dimerization.
  • Receptor phosphorylation and subsequent recruitment of signaling molecules are crucial downstream events.

Purpose of the Study:

  • To investigate whether polyomavirus middle-T antigen forms dimeric signaling complexes, similar to tyrosine kinase growth factor receptors.
  • To determine the roles of membrane association and 14-3-3 protein binding in middle-T antigen dimerization and oncogenic function.

Main Methods:

  • Utilized chimeric middle-T antigen constructs with altered membrane-targeting sequences.
  • Investigated middle-T antigen mutants deficient in 14-3-3 protein association.
  • Assessed dimerization and oncogenic potential of modified middle-T antigen variants.

Main Results:

  • Membrane association is a prerequisite for middle-T antigen multimerization, likely dimer formation.
  • A chimeric middle-T antigen with a viral membrane-targeting sequence retained the ability to dimerize.
  • Mutants lacking 14-3-3 protein binding (d18, S257A) failed to dimerize but remained oncogenic.

Conclusions:

  • Membrane association and 14-3-3 protein binding are both necessary for middle-T antigen dimer formation.
  • Membrane association alone is sufficient for the oncogenic activity of middle-T antigen, independent of dimerization or 14-3-3 binding.

Related Experiment Videos